WallStreetZenWallStreetZen

NASDAQ: IKNA
Ikena Oncology Inc Stock Ownership - Who owns Ikena Oncology?

Insider buying vs selling

Have Ikena Oncology Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IKNA insiders and whales buy or sell their stock.

IKNA Shareholders

What type of owners hold Ikena Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Atlas Venture Life Science Advisors LLC10.40%5,018,178$6.77MInstitution
Bvf Inc9.88%4,769,164$6.44MInstitution
Fmr LLC8.67%4,184,293$5.65MInstitution
Orbimed Advisors LLC7.33%3,539,358$4.78MInstitution
Jean Francois Formela6.01%2,901,609$3.92MInsider
Otello Stampacchia4.66%2,249,123$3.04MInsider
Omega Fund Management LLC4.66%2,249,123$3.04MInstitution
Atlas Venture Fund Xi LP4.39%2,116,569$2.86MInsider
Blue Owl Capital Holdings LP4.05%1,953,616$2.64MInstitution
Blackrock Inc3.85%1,858,156$2.51MInstitution

1 of 3

IKNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IKNA66.60%18.22%
THTX33.01%0.00%
CLGN12.49%0.00%
ALGS54.25%45.75%Net Buying
EQ21.71%40.89%Net Buying

Ikena Oncology Stock Ownership FAQ

Who owns Ikena Oncology?

Ikena Oncology (NASDAQ: IKNA) is owned by 66.60% institutional shareholders, 18.22% Ikena Oncology insiders, and 15.19% retail investors. Jean Francois Formela is the largest individual Ikena Oncology shareholder, owning 2.90M shares representing 6.01% of the company. Jean Francois Formela's Ikena Oncology shares are currently valued at $3.74M.

If you're new to stock investing, here's how to buy Ikena Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.